Anti-CD38 Antibody With KRAS Vaccine and Anti-PD-1 Antibody in Subjects With Pancreatic Ductal Adenocarcinoma and Refractory Non-Small Cell Lung Cancer
PHASE2
The goal of this clinical trial is to test the safety and tolerability of a...
Tg01 Vaccine / Qs-21 Stimulon™ With Or Without Balstilimab As Maintenance Therapy Following Adjuvant Chemotherapy In Patients With Resected Pancreatic Cancer
PHASE2
Researchers want to discover if the new drug "TG01" will work with particip...
Status
Active Not Recruiting
Location
University of Kansas Cancer Center - Clinical Research Center